104 results
8-K
EX-10.2
AVTX
Avalo Therapeutics Inc
28 Mar 24
Avalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 Million
6:08am
8-K
EX-10.1
AVTX
Avalo Therapeutics Inc
28 Mar 24
Avalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 Million
6:08am
8-K
EX-10.1
AVTX
Avalo Therapeutics Inc
26 Sep 23
Avalo Therapeutics Successfully Eliminates $35 Million Debt Paving the Way for Future Growth and Innovation
7:04am
8-K
EX-10.1
AVTX
Avalo Therapeutics Inc
13 Sep 23
Entry into a Material Definitive Agreement
4:03pm
8-K
EX-10.2
AVTX
Avalo Therapeutics Inc
13 Sep 23
Entry into a Material Definitive Agreement
4:03pm
8-K
EX-10.1
0slhw chknl6
14 Aug 23
Entry into a Material Definitive Agreement
4:23pm
8-K
EX-10.1
dvnsb 4atr8e7
21 Jul 23
Entry into a Material Definitive Agreement
8:25am
8-K
EX-10.1
os7728
2 Jun 23
Entry into a Material Definitive Agreement
7:05am
8-K
EX-10.1
1n2tu 45yxvt12mdn
11 Aug 22
Avalo Therapeutics Announces Board Changes
4:03pm
8-K
EX-10.2
8arx45 ldt2t5mq
18 Feb 22
Avalo Therapeutics Announces Leadership Transition
4:01pm
8-K
EX-10.1
ixjcb gkkri0ksjb1el
18 Feb 22
Avalo Therapeutics Announces Leadership Transition
4:01pm